Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (51-60 of 283) with videos related to

Pageof 29
Sort By:
JCO Precision Oncology|January 7, 2022
Pursuing Better Biomarkers for Immunotherapy Response in Cancer Through a Crowdsourced Data ChallengeBenjamin G Vincent, Joseph D Szustakowski, Parul Doshi, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2026
Enhanced antitumor efficacy of combined targeting of adenosine A<sub>2B</sub> receptor and PD-1 is mediated via multiple effects on different cell populations within tumor microenvironmentShuxiao Guan, Cankun Wang, Joseph M Amann, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 11, 2012
Smoking attenuates transforming growth factor-β-mediated tumor suppression function through downregulation of Smad3 in lung cancerDebangshu Samanta, Adriana L Gonzalez, Nagaraj Nagathihalli, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|May 23, 2022
Illness perception profiles and psychological and physical symptoms in newly diagnosed advanced non-small cell lung cancerThomas R Valentine, Carolyn J Presley, David P Carbone, et al.
JCO Precision Oncology|October 23, 2025
Role of Novel Bispecific Antibodies and Immunotherapy in Non-Small Cell Lung Cancer With Common Epidermal Growth Factor Receptor MutationsPo-Lan Su, Peiran Xu, Chien-Chung Lin, et al.
World Journal of Gastroenterology|December 15, 2010
A candidate targeting molecule of insulin-like growth factor-I receptor for gastrointestinal cancersYasushi Adachi, Hiroyuki Yamamoto, Hirokazu Ohashi, et al.
Cancer Research|August 16, 2014
EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signalingRajeswara Rao Arasada, Joseph M Amann, Mohammad A Rahman, et al.
The Journal of Pathology|April 20, 2012
Tumour suppressor Fus1 provides a molecular link between inflammatory response and mitochondrial homeostasisRoman Uzhachenko, Natalia Issaeva, Kelli Boyd, et al.
Cancer Research|August 10, 2011
Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growthYuhui Huang, Luping Lin, Anil Shanker, et al.
Plos One|June 24, 2017
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology settingAmy P Abernethy, Ashwini Arunachalam, Thomas Burke, et al.
Pageof 29

Showing results (51-60 of 283) with videos related to

Sort By:
Pageof 29
JCO Precision Oncology|January 7, 2022
Pursuing Better Biomarkers for Immunotherapy Response in Cancer Through a Crowdsourced Data ChallengeBenjamin G Vincent, Joseph D Szustakowski, Parul Doshi, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2026
Enhanced antitumor efficacy of combined targeting of adenosine A<sub>2B</sub> receptor and PD-1 is mediated via multiple effects on different cell populations within tumor microenvironmentShuxiao Guan, Cankun Wang, Joseph M Amann, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 11, 2012
Smoking attenuates transforming growth factor-β-mediated tumor suppression function through downregulation of Smad3 in lung cancerDebangshu Samanta, Adriana L Gonzalez, Nagaraj Nagathihalli, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|May 23, 2022
Illness perception profiles and psychological and physical symptoms in newly diagnosed advanced non-small cell lung cancerThomas R Valentine, Carolyn J Presley, David P Carbone, et al.
JCO Precision Oncology|October 23, 2025
Role of Novel Bispecific Antibodies and Immunotherapy in Non-Small Cell Lung Cancer With Common Epidermal Growth Factor Receptor MutationsPo-Lan Su, Peiran Xu, Chien-Chung Lin, et al.
World Journal of Gastroenterology|December 15, 2010
A candidate targeting molecule of insulin-like growth factor-I receptor for gastrointestinal cancersYasushi Adachi, Hiroyuki Yamamoto, Hirokazu Ohashi, et al.
Cancer Research|August 16, 2014
EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signalingRajeswara Rao Arasada, Joseph M Amann, Mohammad A Rahman, et al.
The Journal of Pathology|April 20, 2012
Tumour suppressor Fus1 provides a molecular link between inflammatory response and mitochondrial homeostasisRoman Uzhachenko, Natalia Issaeva, Kelli Boyd, et al.
Cancer Research|August 10, 2011
Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growthYuhui Huang, Luping Lin, Anil Shanker, et al.
Plos One|June 24, 2017
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology settingAmy P Abernethy, Ashwini Arunachalam, Thomas Burke, et al.
Pageof 29